Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NSI N.V. | N4RN | Sep 27, 2024 | 20.65 | +0.24 |
NSJ Gold Corp | 9PZ | Sep 27, 2024 | 0.02 | 0.00 |
NSK Ltd. | NSK | Sep 27, 2024 | 4.50 | -2.17 |
NTG Nordic Transport Group | NRSA | Sep 27, 2024 | 39.80 | -0.25 |
NTN Corporation | NTN | Sep 27, 2024 | 1.53 | -4.97 |
NTT Data Corporation | NT5 | Sep 27, 2024 | 16.20 | -1.82 |
NTT DATA GROUP ADR O.N. | NT50 | Sep 27, 2024 | 15.00 | -3.85 |
Nu Holdings Ltd | M1Z | Sep 27, 2024 | 12.50 | +0.53 |
Nu Skin Enterprises, Inc. | NUS | Sep 27, 2024 | 6.25 | +2.46 |
Nubian Resources Ltd | IVHN | Sep 27, 2024 | 0.03 | -19.72 |
Nucleus Financial Group | 0RK | Sep 27, 2024 | 4.64 | +1.31 |
Nucor Corporation | NUO | Sep 27, 2024 | 133.06 | -1.90 |
NuEnergy Gas Limited | NUB | Sep 27, 2024 | 0.01 | -9.09 |
NUERNBERGER Beteiligungs AG | NBG6 | Sep 27, 2024 | 51.00 | -1.92 |
NUEV.EXP.TEX.INH.EO-,016 | B02 | Sep 27, 2024 | 0.29 | +3.89 |
Nufarm Limited | NUF | Sep 27, 2024 | 2.38 | +0.85 |
Nuformix plc | 1RT | Sep 27, 2024 | 0.00 | 0.00 |
NuGen Medical Devices Inc | 79O | Sep 27, 2024 | 0.08 | +14.00 |
NuLegacy Gold Corp | 7NU | Sep 27, 2024 | 0.00 | -95.00 |
Numinus Wellness Inc. | LR23 | Sep 27, 2024 | 0.02 | -2.86 |
Nuran Wireless Inc | 1RNA | Sep 27, 2024 | 0.05 | -6.16 |
NUREXONE BIOLOGIC INC. | J90 | Sep 27, 2024 | 0.37 | 0.00 |
Nurminen Logistics | 8I4 | Sep 27, 2024 | 0.77 | -1.03 |
Nutanix, Inc. - Class A | 0NU | Sep 27, 2024 | 53.40 | -2.16 |
Nutriband Inc | 9WV | Sep 27, 2024 | 5.55 | -2.63 |
Nutrien Ltd | N7T | Sep 27, 2024 | 43.68 | -0.93 |
Nuveen Preferred And Income Term Fund | NU9 | Sep 27, 2024 | 16.84 | -0.28 |
Nuvei | 62E | Sep 27, 2024 | 29.00 | -0.68 |
Nuvista Energy Ltd. | NVG | Sep 27, 2024 | 7.10 | -1.39 |
NV Bekaert SA. | BK8N | Sep 27, 2024 | 36.12 | +1.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.